Navigation Links
Devax Announces Completion of Enrollment of DIVERGE Trial of Novel Drug- Eluting Stent System for Bifurcation Lesions
Date:12/12/2007

- Five hundred patients treated with company's AXXESS(TM) System to date -

LAKE FOREST, Calif., Dec. 12 /PRNewswire/ -- Devax, Inc., a medical device company focused on developing next generation products for interventional cardiology, today announced that the Company has completed patient enrollment in the DIVERGE clinical trial evaluating its novel AXXESS(TM) Bifurcation Stent System. The DIVERGE trial, a prospective, multi-center trial which enrolled 302 patients, is the largest study conducted to date with a drug-eluting stent specifically designed for treating bifurcation lesions.

Bifurcation lesions are areas of atherosclerotic disease occurring at a location where one large vessel divides into two smaller vessels. A number of scientific papers estimate these lesions may occur in more than 500,000 people per year, or approximately 20 percent of all patients undergoing a stenting procedure worldwide.

"The DIVERGE trial and the AXXESS(TM) System are important because of the frequent presentation of bifurcation lesions in our daily clinical practice," said Stefan Verheye, M.D., Ph.D., co-principal investigator of the study and co-director of the Antwerp Cardiovascular Institute at the Middelheim Hospital in Antwerp, Belgium. "Conventional drug-eluting stents are technically challenging to place in bifurcation lesions since they are not designed for the unique anatomical characteristics of coronary bifurcations. As a result, these types of lesions are associated with high complication and restenosis rates compared to conventional lesions. We will submit the data for the next appropriate medical meeting."

To date, more than 500 patients worldwide have been treated using the AXXESS(TM) Bifurcation Stent System. More than 400 patients have received the drug-eluting version of the stent.

"The DIVERGE data will help guide our development and registration strategy to deliver to the market the first drug-eluting stent specifically d
'/>"/>

SOURCE Devax, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... ANT Wireless, proven innovator in ultra-low power (ULP) ... products implementing the ANT+ Fitness Equipment Control (FE-C) profile: ... their bike trainer products, built to create an exciting ... FE-C device profile in its Vortex Smart and Bushido ... training software, while Kinomap has added FE-C support to ...
(Date:6/2/2015)... June 02, 2015 MAP Health Management, ... revenue cycle management for addiction treatment facilities, announced today ... President of Marketing. Mr. Smith will be responsible for ... awareness and visibility of MAP’s core message, products and ... the Marketing Manager at Cottonwood Financial in Irving, Texas, ...
(Date:6/2/2015)... June 02, 2015 DiaTech Oncology, ... response profiling test to help oncologists provide personalized ... of American Pathologists (CAP) for its laboratories in ... certification is equivalent to the ‘Good Housekeeping’ seal ... chief executive officer for DiaTech. “It’s a rigorous ...
(Date:6/2/2015)... 02, 2015 For those that have ... exposed to harmful germs, chemicals and bodily fluids from ... to an inventor from Queens Village, N.Y., their worries ... an efficient, fun, hygienic way to store and dispense ... to bugs, chemicals and germs. Furthermore, it insures that ...
(Date:6/2/2015)... Relias Learning , the ... the healthcare market, is partnering with the National ... complimentary courses relating to mental health and wellness. ... additional resources to better understand and handle difficult ... first responders to situations involving people with mental ...
Breaking Medicine News(10 mins):Health News:First ANT FE-C Enabled Fitness Products Enter Market 2Health News:First ANT FE-C Enabled Fitness Products Enter Market 3Health News:Jared Smith Joins MAP Health Management, LLC, as Vice President of Marketing 2Health News:DiaTech Oncology Gains College of American Pathologists Accreditation for U.S. CorrectChemo Laboratory 2Health News:Dental Storage and Dispensing Unit Invented by InventHelp Client (LGI-1890) 2Health News:Relias Learning Partners with Behavioral Health and Developmental Disabilities Leaders to Offer Complimentary Resources to Public Safety Professionals 2Health News:Relias Learning Partners with Behavioral Health and Developmental Disabilities Leaders to Offer Complimentary Resources to Public Safety Professionals 3
... The Promega ... on in vitro diagnostic medical devices. , ... Madison, WI (PRWEB) March 18, 2010 -- The Promega Maxwell® 16 ... in vitro diagnostic medical devices. The CE mark applies to the instrument, the Maxwell® 16 ...
... cut frequency of seizures in study participants, , THURSDAY, ... the frequency of epileptic seizures in people who had ... found. , The electrical stimulation came from a pacemaker-like ... participants, chest wall. Electrical leads from the device ran ...
... TALLAHASSEE, Fla. , March 18 Allscripts (Nasdaq: MDRX ) announced ... and Practice Management solution to automate and connect clinical and business functions for ... treating patients in the outpatient setting. , ... ...
... premium nutraceuticals for eye health, today announced its new Optometric Advisory Board. , ... , , ... ... The company is pleased to welcome to its Optometric Board ...
... ... and availability of SnapShot Backup for VMWare. SnapShot Backup for VMWare cuts backup time from ... and file level restore., , ... (PRWEB) March 18, 2010 -- SnapShot Backup for VMWare is the New Generation of Backup ...
... the recognized leader and trusted resource for clinical trials management information systems, announced ... Chief Operating Officer. Aulakh comes with an extensive background as engineer, entrepreneur and ... oversee all operating teams to drive continued expansion and market leadership. , ... ...
Cached Medicine News:Health News:Promega Maxwell 16 IVD System CE Marked to the European Union IVD Directive Delivers Combined Solution for Infectious Disease 2Health News:Implant Shows Promise for Hard-to-Treat Epilepsy 2Health News:Tallahassee Memorial HealthCare Selects Allscripts Electronic Health Record and Practice Management for More Than 100 Providers 2Health News:Tallahassee Memorial HealthCare Selects Allscripts Electronic Health Record and Practice Management for More Than 100 Providers 3Health News:Tallahassee Memorial HealthCare Selects Allscripts Electronic Health Record and Practice Management for More Than 100 Providers 4Health News:Tallahassee Memorial HealthCare Selects Allscripts Electronic Health Record and Practice Management for More Than 100 Providers 5Health News:Tallahassee Memorial HealthCare Selects Allscripts Electronic Health Record and Practice Management for More Than 100 Providers 6Health News:Tallahassee Memorial HealthCare Selects Allscripts Electronic Health Record and Practice Management for More Than 100 Providers 7Health News:Tallahassee Memorial HealthCare Selects Allscripts Electronic Health Record and Practice Management for More Than 100 Providers 8Health News:ScienceBased Health(R) Announces New Optometric Advisory Board to Expand Awareness of Nutrition's Role in Eye Care 2Health News:ScienceBased Health(R) Announces New Optometric Advisory Board to Expand Awareness of Nutrition's Role in Eye Care 3Health News:ScienceBased Health(R) Announces New Optometric Advisory Board to Expand Awareness of Nutrition's Role in Eye Care 4Health News:ScienceBased Health(R) Announces New Optometric Advisory Board to Expand Awareness of Nutrition's Role in Eye Care 5Health News:SAN SnapShot Backup for VMWare - Does Your Backup Always Completes In Seconds, Is 1000x Faster and Costs 90% Less? 2Health News:SAN SnapShot Backup for VMWare - Does Your Backup Always Completes In Seconds, Is 1000x Faster and Costs 90% Less? 3Health News:Kamar Aulakh Joins Velos, Inc. as Chief Operating Officer 2Health News:Kamar Aulakh Joins Velos, Inc. as Chief Operating Officer 3Health News:Kamar Aulakh Joins Velos, Inc. as Chief Operating Officer 4
(Date:6/2/2015)... June 2, 2015 Today the Council ... 150 major food companies, retailers, and human and ... on Antibiotic Stewardship. CSTE is committed to supporting ... detect resistant strains, preserve the efficacy of our ... infections. CSTE continues to serve as ...
(Date:6/2/2015)... 2015 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ... from the U.S. Food and Drug Administration (FDA) of ... Oral Solution 5mg/5mL. Trailing twelve-month sales for the product ... competitors. ANI expects to begin shipping to its customers ... and CEO of ANI Pharmaceuticals, stated, "This ANDA represents ...
(Date:6/2/2015)... Oramed Pharmaceuticals Inc. (NASDAQ: ... focused on the development of oral drug delivery systems, ... with ORMD-0801, its orally ingestible insulin capsule on type ... sessions in the ADA 75 th Scientific Sessions ... . The poster will be attended by Oramed,s Chief ...
Breaking Medicine Technology:ANI Pharmaceuticals Announces FDA Approval of Oxycodone Hydrochloride Oral Solution 5mg/5mL 2ANI Pharmaceuticals Announces FDA Approval of Oxycodone Hydrochloride Oral Solution 5mg/5mL 3Oramed to Present at the American Diabetes Association 75th Scientific Sessions 2Oramed to Present at the American Diabetes Association 75th Scientific Sessions 3Oramed to Present at the American Diabetes Association 75th Scientific Sessions 4
Inquire...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: